What is the recommended dose of Gardenal (phenobarbital) for seizure management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Phenobarbital (Gardenal) Dosing for Seizure Management

For status epilepticus in adults, phenobarbital should be administered at 15-20 mg/kg IV over 10-15 minutes, with a maximum initial dose of 1000 mg. 1

Dosing Guidelines by Age Group and Indication

Adults

  • Status epilepticus: 20-320 mg IV, may be repeated in 6 hours as necessary 1
    • Loading dose: 15-20 mg/kg IV over 10-15 minutes 1
    • Maximum initial dose: 1000 mg 2
  • Maintenance therapy: 30-120 mg daily in 2-3 divided doses 1

Children

  • Status epilepticus: 15-20 mg/kg IV over 10-15 minutes 2, 1
  • Anticonvulsant therapy: 4-6 mg/kg/day for 7-10 days to achieve blood level of 10-15 mcg/mL 1
  • Alternative dosing: 10-15 mg/kg/day IM or IV 1

Neonates

  • Seizures: 10 mg/kg IV 2
  • Maintenance therapy: 3-4 mg/kg/day 3

Administration Guidelines

Intravenous Administration

  • Rate of administration: Should not exceed 60 mg/min for adults 1
  • Site selection: Use larger veins; avoid small veins on dorsum of hand or wrist 1
  • Monitoring: Continuous monitoring of vital signs, including blood pressure, respiration, and cardiac function is essential 1

Safety Precautions

  • Equipment for resuscitation and artificial ventilation should be available during administration 1
  • Avoid administration into varicose veins due to retarded circulation 1
  • Careful technique, including aspiration, is necessary to avoid inadvertent intraarterial injection 1

Therapeutic Considerations

Therapeutic Levels

  • Target blood level: 10-15 mcg/mL for anticonvulsant effect 1
  • For partial seizures, higher plasma concentrations (approximately 37 mcg/mL) may be necessary compared to tonic-clonic seizures alone (18 mcg/mL) 4

Pharmacokinetics

  • Long half-life (62-103 hours) allows for less frequent dosing but increases risk of accumulation 5
  • In children with severe malaria and seizures, a loading dose of 15 mg/kg IV achieves plasma concentrations >15 mg/mL with good clinical effect 5

Special Considerations

Potential Adverse Effects

  • Respiratory depression and hypotension due to vasodilatory and cardiodepressant effects 2
  • Increased risk of respiratory depression when combined with other sedative agents 2
  • Be prepared to provide respiratory support and monitor oxygen saturation 2

Efficacy Considerations

  • In status epilepticus, phenobarbital has been shown to be equally efficacious compared to lorazepam, phenytoin, and phenytoin plus diazepam 2
  • Status epilepticus duration may be shorter with phenobarbital use, with 61% of patients not requiring additional anticonvulsants 2

Cautions

  • Parenteral routes should only be used when oral administration is impossible or impractical 1
  • Intramuscular injections should be made deeply into a large muscle, with volume not exceeding 5 mL at any one site 1
  • Injection into or near peripheral nerves may result in permanent neurological deficit 1

Remember that phenobarbital dosing must be individualized based on patient's age, weight, and clinical condition, with careful monitoring of therapeutic response and adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Phenobarbital in newborn infants. Overview].

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.